Advancements in Previously Untreated Patients with DLBCL

G

Treatment Landscape in 1L DLBCL: Polatuzumab Vedotin as SoC

By Georg Lenz
292 views
June 27, 2024
Comments 0
Login to view comments. Click here to Login
22:11

Has the 1L SoC Truly Changed in Advanced Stage DLBCL?

SOHO Brazil 2024

A. Zelenetz

619 views
20:25

What Is the Best Timing for Bispecific Antibodies and CAR-T Therapy …

SOHO Brazil 2024

A. Zelenetz

64 views
15:02

Summary of Updates in R/R DLBCL Treatment

SOHO Brazil 2024

A. Alencar

111 views
37:44

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

University of Colorado Division of Hematology

M. Kamdar

254 views
15:26

R/R DLBCL: Are CAR-Ts Superior to Bispecific Antibodies?

Moffitt Cancer Center

A. Lazaryan

341 views
04:29

Polatuzumab Vedotin in 1L DLBCL: Perspectives on the POLARIX Trial

Juan Pablo Alderuccio

234 views
31:12

Practice-Changing Abstracts in NHL and HL From ASH 2023

UChicago Medicine

S. Smith

405 views
04:37

POLARIX Trial Recap: Using Polatuzumab Vedotin for Previously Untrea…

Thomas Melchardt

88 views
35:24

State of the Art and Next Questions: Aggressive B-Cell Lymphomas

SOHO Highlights: State of the Art and Next Questions

G. Nowakowski

409 views
29:26

Practice-Changing Updates in DLBCL and HL

Massachusetts General Hospital Cancer Center

J. Erika Haydu

338 views
22:09

New Updates in Frontline DLBCL

Scripps Health

L. Nastoupil

713 views
15:29

Current Standards of Care for Aggressive Lymphomas

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

U. Vitolo

218 views
09:32

Upfront Management of DLBCL

SOHO 2023 Eleventh Annual Meeting

C. Flowers

248 views
35:27

Updates on Management of DLBCL

Louisville Hematology Highlights

J. Leonard

710 views
27:47

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Indy Hematology Review

S. Smith

715 views
04:04

Polatuzumab Vedotin for 1L DLBCL: Results From the POLARIX Trial

Wojciech Jurczak

347 views